Healthcare -
Biotechnology - NASDAQ - US
$ 39.3
1.58 %
$ 11 B
Market Cap
22.33
P/E
EXEL - OTHER CURRENT LIABILITIES
Other Current Liabilities EXEL - Exelixis, Inc.
366 M
LAST VALUE
13.42%
2 YEAR CAGR
23.27%
5 YEAR CAGR
19.11%
10 YEAR CAGR